ReShape Lifesciences issues $833,333 senior secured convertible note to institutional investor

Vyome Holdings, Inc

Issued $833,333.34 convertible note with 10% annual interest, due Jan 16, 2025 or upon close of Vyome merger.
Investor received 7,983 shares of common stock as commitment shares in connection with the note.
Note is secured by substantially all assets of ReShape Lifesciences, including intellectual property and patents.
Directors and officers entered lock-up agreements barring disposal of company shares while note is outstanding.
Investor agreed to a leak-out restriction limiting daily sales to 10% of composite trading volume of RSLS.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.